Aster DM Healthcare Share Price
Sector: Healthcare Facilities
345.00 -1.90 (-0.55%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
343.25
Today’s High
349.95
52 Week Low
213.44
52 Week High
430.11
345.15 -1.60 (-0.46%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
343.35
Today’s High
349.9
52 Week Low
216.45
52 Week High
429.74
Key Metrics
- Market Cap (In Cr) 17260.28
- Beta 1.31
- Div. Yield (%) 0.58
- P/B 3.79
- TTM P/E 536.61
- Peg Ratio 0.7
- Sector P/E 26.76
- D/E 0.3
- Open Price 347
- Prev Close 346.9
Aster DM Healthcare Analysis
Price Analysis
-
1 Week-1.55%
-
3 Months7.74%
-
6 Month13.03%
-
YTD9.87%
-
1 Year38.24%
Risk Meter
- 40% Low risk
- 40% Moderate risk
- 40% Balanced Risk
- 40% High risk
- 40% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 3
- 3
- 3
- 3
- Buy
- 3
- 3
- 3
- 2
- Hold
- 0
- 0
- 0
- 0
- Sell
- 0
- 0
- 0
- 0
- Strong Sell
- 0
- 0
- 0
- 0
- Total
- 6
- 6
- 6
- 5
Aster DM Healthcare News
Apollo to Aster, Manipal to Max, hospital chains ready for a big-bang expansion
4 min read . 24 May 2024Fortis Malar Hospitals, Aster DM Healthcare, shares to trade ex-dividend today
2 min read . 23 Apr 2024ICICI Securities, Aster DM Healthcare, others to trade ex-dividend next week
1 min read . 20 Apr 2024Stocks to Watch: Jio Financial, Vi, Aster DM, Cipla, Asian Paints
5 min read . 16 Apr 2024Aster DM Healthcare Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 3698.9
- Selling/ General/ Admin Expenses Total
- 675.93
- Depreciation/ Amortization
- 219.97
- Other Operating Expenses Total
- 713.53
- Total Operating Expense
- 3340.92
- Operating Income
- 357.98
- Net Income Before Taxes
- 261.19
- Net Income
- 129.28
- Diluted Normalized EPS
- 2.46
- Period
- 2024
- Total Assets
- 17991.31
- Total Liabilities
- 13431.52
- Total Equity
- 4559.79
- Tangible Book Valueper Share Common Eq
- 85.67
- Period
- 2024
- Cashfrom Operating Activities
- 157.81
- Cashfrom Investing Activities
- -884.65
- Cashfrom Financing Activities
- 1052.83
- Net Changein Cash
- 332.39
- Period
- 2023
- Total Revenue
- 11932.88
- Selling/ General/ Admin Expenses Total
- 5351.36
- Depreciation/ Amortization
- 780.44
- Other Operating Expenses Total
- 295.79
- Total Operating Expense
- 11146.7
- Operating Income
- 786.18
- Net Income Before Taxes
- 535.08
- Net Income
- 424.91
- Diluted Normalized EPS
- 8.43
- Period
- 2023
- Total Assets
- 14881.2
- Total Liabilities
- 10433.13
- Total Equity
- 4448.07
- Tangible Book Valueper Share Common Eq
- 58.72
- Period
- 2023
- Cashfrom Operating Activities
- 1833.98
- Cashfrom Investing Activities
- -971.88
- Cashfrom Financing Activities
- -817.39
- Net Changein Cash
- 65.74
- Period
- 2022
- Total Revenue
- 10253.28
- Selling/ General/ Admin Expenses Total
- 4491.38
- Depreciation/ Amortization
- 640.58
- Other Operating Expenses Total
- 450.57
- Total Operating Expense
- 9409.35
- Operating Income
- 843.93
- Net Income Before Taxes
- 636.85
- Net Income
- 525.99
- Diluted Normalized EPS
- 10.57
- Period
- 2022
- Total Assets
- 12546.24
- Total Liabilities
- 8592.83
- Total Equity
- 3953.41
- Tangible Book Valueper Share Common Eq
- 52.04
- Period
- 2022
- Cashfrom Operating Activities
- 1313.46
- Cashfrom Investing Activities
- -570.48
- Cashfrom Financing Activities
- -685.42
- Net Changein Cash
- 64.78
- Period
- 2021
- Total Revenue
- 8608.43
- Selling/ General/ Admin Expenses Total
- 3807.17
- Depreciation/ Amortization
- 617.57
- Other Operating Expenses Total
- 436.12
- Total Operating Expense
- 8160.92
- Operating Income
- 447.51
- Net Income Before Taxes
- 205.05
- Net Income
- 147.74
- Diluted Normalized EPS
- 2.97
- Period
- 2021
- Total Assets
- 11643.46
- Total Liabilities
- 8271
- Total Equity
- 3372.46
- Tangible Book Valueper Share Common Eq
- 41.65
- Period
- 2021
- Cashfrom Operating Activities
- 1569.12
- Cashfrom Investing Activities
- -330.3
- Cashfrom Financing Activities
- -1116.13
- Net Changein Cash
- 119.9
- Period
- 2020
- Total Revenue
- 8651.88
- Selling/ General/ Admin Expenses Total
- 3849.46
- Depreciation/ Amortization
- 585.94
- Other Operating Expenses Total
- 204.31
- Total Operating Expense
- 7999.28
- Operating Income
- 652.6
- Net Income Before Taxes
- 330.04
- Net Income
- 276.61
- Diluted Normalized EPS
- 5.97
- Period
- 2020
- Total Assets
- 12437.84
- Total Liabilities
- 9165.7
- Total Equity
- 3272.14
- Tangible Book Valueper Share Common Eq
- 39.78
- Period
- 2020
- Cashfrom Operating Activities
- 1223.25
- Cashfrom Investing Activities
- -667.28
- Cashfrom Financing Activities
- -674.8
- Net Changein Cash
- -109.92
- Period
- 2019
- Total Revenue
- 7962.71
- Selling/ General/ Admin Expenses Total
- 3525.97
- Depreciation/ Amortization
- 306.47
- Other Operating Expenses Total
- 449.9
- Total Operating Expense
- 7405.45
- Operating Income
- 557.26
- Net Income Before Taxes
- 410.25
- Net Income
- 333.11
- Diluted Normalized EPS
- 6.62
- Period
- 2019
- Total Assets
- 8936.41
- Total Liabilities
- 5722.65
- Total Equity
- 3213.76
- Tangible Book Valueper Share Common Eq
- 44.48
- Period
- 2019
- Cashfrom Operating Activities
- 583.55
- Cashfrom Investing Activities
- -691.54
- Cashfrom Financing Activities
- 134.42
- Net Changein Cash
- 32.93
- Period
- 2018
- Total Revenue
- 6721.16
- Selling/ General/ Admin Expenses Total
- 3232.94
- Depreciation/ Amortization
- 297.74
- Other Operating Expenses Total
- 209.56
- Total Operating Expense
- 6271
- Operating Income
- 450.16
- Net Income Before Taxes
- 307.76
- Net Income
- 268.88
- Diluted Normalized EPS
- 3.18
- Period
- 2018
- Total Assets
- 7484.24
- Total Liabilities
- 4652.14
- Total Equity
- 2832.09
- Tangible Book Valueper Share Common Eq
- 40.76
- Period
- 2018
- Cashfrom Operating Activities
- 537.35
- Cashfrom Investing Activities
- -522.53
- Cashfrom Financing Activities
- 45.68
- Net Changein Cash
- 60.63
- Period
- 2024-03-31
- Total Revenue
- 973.59
- Selling/ General/ Admin Expenses Total
- 170.89
- Depreciation/ Amortization
- 58.36
- Other Operating Expenses Total
- 191.46
- Total Operating Expense
- 872.61
- Operating Income
- 100.98
- Net Income Before Taxes
- 72.32
- Net Income
- -24.03
- Diluted Normalized EPS
- 0.4
- Period
- 2024-03-31
- Total Assets
- 17991.31
- Total Liabilities
- 13431.52
- Total Equity
- 4559.79
- Tangible Book Valueper Share Common Eq
- 85.67
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 157.81
- Cashfrom Investing Activities
- -884.65
- Cashfrom Financing Activities
- 1052.83
- Net Changein Cash
- 332.39
- Period
- 2023-12-31
- Total Revenue
- 3710.61
- Selling/ General/ Admin Expenses Total
- 1162.2
- Depreciation/ Amortization
- 231.54
- Other Operating Expenses Total
- 582.82
- Total Operating Expense
- 3378.01
- Operating Income
- 332.6
- Net Income Before Taxes
- 233.46
- Net Income
- 179.21
- Diluted Normalized EPS
- 3.6
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 3316.63
- Selling/ General/ Admin Expenses Total
- 1129.89
- Depreciation/ Amortization
- 227.16
- Other Operating Expenses Total
- 552.53
- Total Operating Expense
- 3221.14
- Operating Income
- 95.49
- Net Income Before Taxes
- -5.16
- Net Income
- -30.79
- Diluted Normalized EPS
- 0.09
- Period
- 2023-09-30
- Total Assets
- 15708.35
- Total Liabilities
- 11335.32
- Total Equity
- 4373.03
- Tangible Book Valueper Share Common Eq
- 56.61
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 818.16
- Cashfrom Investing Activities
- -419.49
- Cashfrom Financing Activities
- -341.28
- Net Changein Cash
- 61.74
- Period
- 2023-06-30
- Total Revenue
- 3215.37
- Selling/ General/ Admin Expenses Total
- 1090.8
- Depreciation/ Amortization
- 217.46
- Other Operating Expenses Total
- 484.38
- Total Operating Expense
- 3045.12
- Operating Income
- 170.25
- Net Income Before Taxes
- 73.25
- Net Income
- 4.9
- Diluted Normalized EPS
- 0.1
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 3262.32
- Selling/ General/ Admin Expenses Total
- 987.56
- Depreciation/ Amortization
- 218.6
- Other Operating Expenses Total
- 549.5
- Total Operating Expense
- 2974.84
- Operating Income
- 287.48
- Net Income Before Taxes
- 205.78
- Net Income
- 170.77
- Diluted Normalized EPS
- 3.43
- Period
- 2023-03-31
- Total Assets
- 14881.2
- Total Liabilities
- 10433.13
- Total Equity
- 4448.07
- Tangible Book Valueper Share Common Eq
- 58.72
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 1833.98
- Cashfrom Investing Activities
- -971.88
- Cashfrom Financing Activities
- -817.39
- Net Changein Cash
- 65.74
- Period
- 2022-12-31
- Total Revenue
- 3192.14
- Selling/ General/ Admin Expenses Total
- 1042.99
- Depreciation/ Amortization
- 197.51
- Other Operating Expenses Total
- 481.28
- Total Operating Expense
- 2941.97
- Operating Income
- 250.17
- Net Income Before Taxes
- 173.44
- Net Income
- 139.39
- Diluted Normalized EPS
- 2.8
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Aster DM Healthcare Technical
Moving Average
SMA
- 5 Day349.1
- 10 Day353.85
- 20 Day355.51
- 50 Day359.66
- 100 Day350.81
- 300 Day316.68
Aster DM Healthcare Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Narayana Hrudayalaya
- 1242.75
- 17.6
- 1.44
- 1445.05
- 972.05
- 25240.23
- Dr. Lal Pathlabs
- 2907.75
- 87.45
- 3.1
- 2889.45
- 1943.2
- 24196.28
- Aster DM Healthcare
- 345
- -1.9
- -0.55
- 430.11
- 213.44
- 17173.17
- Krishna Instit Of Medical Sciences
- 2133.75
- 12.55
- 0.59
- 2357
- 1625.05
- 17075.97
- Rainbow Childrens Medicare
- 1320
- 22
- 1.69
- 1649
- 880.05
- 13398.26
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Narayana Hrudayalaya
- 31.46
- 8.61
- 23.44
- 9.72
- Dr. Lal Pathlabs
- 64.67
- 12.51
- 21.32
- 15.99
- Aster DM Healthcare
- 142.1
- 3.82
- 6.24
- 4.26
- Krishna Instit Of Medical Sciences
- 54.04
- 9.17
- 22.79
- 15.53
- Rainbow Childrens Medicare
- 58.77
- 10.13
- 19.88
- 13.8
Aster DM Healthcare Shareholding
Shareholding Pattern
*Promoter pledging: 41.41%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 28-May-24
- Audited Results & Final Dividend
- 12-Apr-24
- Interim Dividend & Special Dividend
- 08-Feb-24
- Quarterly Results
- 14-Nov-23
- Quarterly Results
- 14-Aug-23
- Quarterly Results
- 25-May-23
- Audited Results
- 14-Feb-23
- Quarterly Results
- 10-Nov-22
- Quarterly Results
- 11-Aug-22
- Quarterly Results
- 24-May-22
- Audited Results
- Meeting Date
- Announced on
- Purpose
- 24-Jan-24
- 26-Dec-23
- POM
- 31-Aug-23
- 25-May-23
- AGM
- 10-Apr-23
- 09-Mar-23
- POM
- 25-Aug-22
- 24-May-22
- AGM
- 22-Mar-22
- 16-Feb-22
- POM
- 13-Aug-21
- 24-Jun-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 28-May-24
- 22-Aug-24
- -
- 2
- 05-Apr-24
- 23-Apr-24
- 23-Apr-24
- 118
![No data](https://www.livemint.com/lm-img/dev/null-data.png)
![No data](https://www.livemint.com/lm-img/dev/null-data.png)
![No data](https://www.livemint.com/lm-img/dev/null-data.png)